MediPress Health – Limited Partnership has completed an IPO
MediPress Health – Limited Partnership has completed a fundraising to refinance and develop the business.
The venture MediPress Health – Limited Partnership is a public R&D life science partnership that invests in medical R&D companies specialized in digital and advanced breakthrough technologies. The venture is managed by an accomplished team with proven experience and an innovative team from the medical, technology and investments industry.
Oaklins’ team in Israel advised the company and acted as the leader of the distributors’ consortium.
Talk to the deal team
Related deals
IMD International Medical Devices has aised funds
IMD International Medical Devices has completed an IPO on the Euronext Growth Milan market, raising a total of US$6.5 million. The funds will be used to strengthen its competitive positioning in the market and implementing a growth strategy, both in Italy and abroad.
Learn morePilulka Lékárny has completed an SPO on the START Market of the Prague Stock Exchange
Pilulka Lékárny, a.s. has completed an SPO on the START Market of the Prague Stock Exchange consisting of a capital increase through subscription of new shares. The funds will be used to further develop the company, particularly to strengthen its working capital, to bolster its activities in international markets and to further develop its own e-health solutions.
Learn moreSAT Health expands its outpatient care by acquiring Blocks Medical Center
Blocks Health and Social Care has sold Blocks Medical Center Mladost to SAT Health, a private equity-backed healthcare data analytics and outpatient care provider.
Learn more